Do GLP-1 users actually need protein at breakfast?

What did @losingitwith3kids actually say?

The creator, who says she's on a GLP-1 medication, explained that most mornings she's "just not that hungry" and finds a full breakfast hard to get down. Her solution: skip the big meal, focus on protein instead. Her go-to options are protein shakes blended with fruit, and low-fat cottage cheese with berries and a small amount of maple syrup. The core argument is that "the goal isn't to make some big breakfast, it's just to get protein in so you're not playing catch-up later in the day." She also warns that skipping entirely causes energy crashes and cravings. This is personal experience content, not medical advice, and she frames it that way throughout.

The claims are narrow and practical: reduced appetite on GLP-1s is real, protein helps, and skipping meals entirely may backfire. Let's look at whether the evidence agrees.

Does the science back this up?

Mostly, yes. The appetite-suppressing effects of GLP-1 receptor agonists are well-documented, and protein's role in satiety is one of the more robust findings in nutrition research. But the "skipping leads to cravings" claim is a little more complicated than she makes it sound.

GLP-1 medications like semaglutide slow gastric emptying and act on hypothalamic appetite centers, which genuinely does make many users uninterested in food, especially in the morning. A 2021 trial by Wilding et al. in the New England Journal of Medicine confirmed significant appetite reduction as a primary mechanism in semaglutide-treated patients. On protein: a 2015 review by Leidy et al. in the American Journal of Clinical Nutrition found that higher protein intake increases satiety hormones and reduces ghrelin, the hunger-signaling hormone. The 25-30g protein range at breakfast was specifically associated with reduced later-day hunger.

The "skipping causes energy crashes" argument has support too, but it is more conditional. Studies in general populations show meal skipping can disrupt blood glucose regulation, but in people on GLP-1 therapy whose insulin response is already being modulated, the picture is less straightforward. It is not wrong, it is just not as universal as she implies.

What did they get wrong (or right)?

She got the main points right, and the things she got wrong are more about oversimplification than misinformation.

Right: reduced appetite on GLP-1s is not a personal quirk, it is a pharmacological effect, and acknowledging it instead of forcing a big meal is actually aligned with clinical guidance. Protein prioritization is genuinely supported. Her food choices, cottage cheese, Greek yogurt, protein shakes, are high-quality protein sources with reasonable leucine content, which matters for muscle protein synthesis. This is not nothing, especially since GLP-1-induced caloric restriction carries a real risk of lean mass loss if protein intake is inadequate. Research by Biolo et al. (1997, American Journal of Physiology) and more recent work by Volpi et al. suggests that distributing protein across meals, including breakfast, supports muscle maintenance during weight loss.

Where she oversimplifies: the claim that skipping breakfast "always" leads to bad outcomes is not universally true. Intermittent fasting protocols, which often skip breakfast, have their own evidence base. The mechanism she describes, energy drops and cravings, is plausible but not inevitable. For some GLP-1 users, particularly those with very low appetites, skipping one meal may be medically appropriate under supervision. She presents one personal strategy as broadly applicable, which is a stretch.

What should you actually know?

If you are on a GLP-1 medication and struggling to eat in the morning, the practical advice here is reasonable but should be put in clinical context. The biggest nutrition risk for people on GLP-1 therapy is not skipping breakfast. It is total protein and caloric intake falling too low over the course of the day, which can accelerate muscle loss alongside fat loss.

A 2023 analysis by Suchindran et al. in Obesity Reviews noted that patients on semaglutide who did not meet protein targets lost significantly more lean mass than those who did. The current general guidance from obesity medicine specialists typically targets 1.2 to 1.6 grams of protein per kilogram of body weight per day during active weight loss, though your prescriber should set your specific target based on your health profile.

Her instinct to anchor the morning around protein rather than carbohydrates or skipping entirely is sound. But "a spoonful of maple syrup" on cottage cheese is not a problem either. Anyone who tells you that one small sugar addition will derail GLP-1 therapy is not reading the same research.

• Reduced morning appetite is a documented pharmacological effect of GLP-1 medications, not a sign something is wrong.
• Prioritizing protein at breakfast has evidence behind it for satiety and muscle preservation.
• Skipping meals entirely on GLP-1s is not automatically harmful, but consistently low protein intake is a documented concern.
• Consult your prescriber or a registered dietitian if you are consistently struggling to meet protein targets, not a TikTok comment section.